reported that ANGPTL2 enhanced angiogenesis in osteosarcoma by upregulating the expression of HK2 and VEGF, and treatment with 2-DG could reversed this outcome (81) (Table 1). This evidence concerns the gene ANGPTL2 and osteosarcoma.